Internal Medicine, Pulmonary Disease · New Orleans, LA
NPI
1245542653
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-3925
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
431 services
Medicare patients, 2024
111
Average age 69
Drug cost, 2024
$1.9M
2,919 prescriptions
Company payments, 2025
$377
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ishna Poojary-Hohman was code 99233 (hospital e&m - subsequent), 168 times for 31 patients. In total Ishna Poojary-Hohman billed 431 services in 16 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 168 | 31 | $92.29 | $16K |
| 99215 Office E&M - Established | Facility | 141 | 87 | $108.78 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 16 | $61.19 | $2,448 |
| 99223 Hospital E&M - Initial | Facility | 28 | 19 | $134.83 | $3,775 |
| 99213 Office E&M - Established | Facility | 18 | 15 | $49.99 | $900 |
By year: 2022 $8,040 for 132 services; 2023 $17K for 168 services; 2024 $41K for 431 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ishna Poojary-Hohman prescribed most often to Medicare patients was Azithromycin, with 303 prescriptions and refills. In total Ishna Poojary-Hohman wrote 2,919 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 303 | 680 | 110 | $5,176 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 273 | 536 | 84 | $1,389 |
| Prednisone Generic | 217 | 461 | 80 | $1,306 |
| Tacrolimus Generic | 153 | 323 | 50 | $13K |
| Pantoprazole Sodium Generic | 102 | 266 | 46 | $1,244 |
| Valacyclovir Valacyclovir Hcl | 86 | 202 | 29 | $3,560 |
| Montelukast Sodium Generic | 65 | 159 | 26 | $636 |
| Mycophenolate Mofetil Generic | 65 | 103 | 18 | $5,971 |
| Metoprolol Tartrate Generic | 58 | 134 | 22 | $548 |
| Atovaquone Generic | 57 | 81 | 21 | $36K |
| Valganciclovir Hcl Generic | 51 | 125 | 29 | $19K |
| Famotidine Generic | 50 | 127 | 25 | $566 |
| Propranolol Hcl Generic | 44 | 56 | 11 | $494 |
| Eliquis Apixaban | 43 | 98 | 19 | $56K |
| Itraconazole Generic | 42 | 96 | 18 | $18K |
Brand drugs: 403 claims; generic drugs: 2,480 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ishna Poojary-Hohman $377 ($377 in general payments such as food, travel and fees) from 6 companies. The largest payer was United Therapeutics Corporation with $265.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.